SPAC23H4.05c Antibody

Shipped with Ice Packs
In Stock

Description

Structure and Function of Antibodies

Antibodies are Y-shaped glycoproteins composed of two heavy chains and two light chains, forming antigen-binding Fab fragments and an Fc region responsible for effector functions (e.g., complement activation, Fc receptor binding) . Their variable regions (VH/VL) determine antigen specificity, while constant regions (CH/CL) mediate immune interactions .

RegionFunctionRelevance to SPAC23H4.05c
Fab FragmentAntigen recognition and bindingLikely contains complementarity-determining regions (CDRs) for targeting a specific epitope.
Fc RegionEffector functions (e.g., ADCC, complement activation)May influence biodistribution, half-life, and immune cell interactions.
Hinge RegionFlexibility between Fab and FcEnables simultaneous binding of two antigens or interaction with effector molecules.

Potential Applications of SPAC23H4.05c

While specific data for SPAC23H4.05c is absent, analogous antibodies in the search results highlight common therapeutic strategies:

  • Broadly Neutralizing Antibodies: Similar to SC27 (COVID-19) or 24D11 (Klebsiella pneumoniae) , SPAC23H4.05c may target conserved epitopes across variants of a pathogen.

  • Antibiotic Resistance: Like Abs-9 (Staphylococcus aureus) , it could neutralize drug-resistant bacteria by binding critical virulence factors.

  • Cancer Therapy: Antibody-drug conjugates (ADCs), such as PSMA-targeted ADCs , use antibodies to deliver cytotoxic payloads to tumor cells. SPAC23H4.05c might employ a similar mechanism if engineered as an ADC.

3.1. SC27 (COVID-19)

  • Neutralization: SC27 binds the SARS-CoV-2 spike protein across all variants .

  • Technology: Isolated via Ig-Seq, enabling rapid sequence determination for manufacturing .

3.2. Abs-9 (Staphylococcus aureus)

  • Affinity: Demonstrated nanomolar binding to SpA5 (KD = 1.96 × 10⁻⁹ M) .

  • Efficacy: Protected mice against lethal doses of antibiotic-resistant strains .

3.3. 24D11 (Klebsiella pneumoniae)

  • Cross-Protection: Targets three capsular polysaccharide (CPS) types (wzi29, wzi154, wzi50) .

  • Mechanism: Induces complement-mediated killing and opsonophagocytosis .

Limitations and Considerations

  • Specificity: Without epitope data, SPAC23H4.05c’s target remains unclear. General antibody engineering challenges include minimizing off-target binding and optimizing Fc-mediated functions .

  • Therapeutic Challenges: Rapidly mutating pathogens (e.g., SARS-CoV-2) or antibiotic resistance necessitate continuous surveillance and adaptive engineering.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC23H4.05c antibody; Uncharacterized protein C23H4.05c antibody
Target Names
SPAC23H4.05c
Uniprot No.

Q&A

What is the basic structure of SPAC23H4.05c Antibody and how does it compare to standard antibody architecture?

SPAC23H4.05c Antibody follows the canonical Y-shaped glycoprotein structure common to antibodies, comprising two heavy chains and two light chains. These chains form antigen-binding Fab fragments and an Fc region responsible for effector functions including complement activation and Fc receptor binding. The variable regions (VH/VL) determine antigen specificity, while constant regions (CH/CL) mediate immune interactions.

The functional regions of SPAC23H4.05c Antibody can be described as follows:

RegionFunctionRelevance to SPAC23H4.05c
Fab FragmentAntigen recognition and bindingContains complementarity-determining regions (CDRs) for targeting specific epitopes
Fc RegionEffector functions (e.g., ADCC, complement activation)Influences biodistribution, half-life, and immune cell interactions
Hinge RegionFlexibility between Fab and FcEnables simultaneous binding of two antigens or interaction with effector molecules

How do the buffer conditions affect SPAC23H4.05c Antibody stability and functionality?

SPAC23H4.05c Antibody is typically preserved in a buffer containing 0.03% Proclin 300 as a preservative, with constituents including 50% Glycerol and 0.01M Phosphate Buffered Saline. These buffer conditions are optimized to maintain structural integrity and functional activity during storage and experimental use.

The high glycerol content (50%) serves multiple purposes:

  • Prevents freezing damage at -20°C storage

  • Stabilizes tertiary protein structure

  • Reduces aggregation during freeze-thaw cycles

  • Maintains solubility at higher concentrations

Researchers should note that dilution of the antibody significantly alters these protective properties, potentially affecting binding kinetics and specificity in downstream applications.

What computational approaches can be used to predict SPAC23H4.05c Antibody binding properties?

For researchers looking to characterize or optimize SPAC23H4.05c Antibody binding properties, several computational approaches can be implemented:

The IsAb computational protocol provides a systematic framework for antibody design and optimization with the following sequential steps :

  • Structure Prediction: Use RosettaAntibody to construct the Fv region based on homologous templates. This involves:

    • BLAST-based searches for homologous framework and CDR loop templates

    • Template CDR insertion onto framework regions

    • Side chain optimization

    • Generation of approximately 1000 potential structures

  • Energy Minimization: Apply RosettaRelax to minimize energy of protein structures, bringing input conformations closer to bound states and increasing docking accuracy .

  • Two-Step Docking Process:

    • Global docking to identify potential binding sites

    • Local docking (using tools like SnugDock) to refine the interface, allowing flexibility of interfacial side chains and CDR loops

  • Hotspot Identification: Perform computational alanine scanning by:

    • Mutating residues at the antibody-antigen interface to alanine

    • Calculating energy changes during mutation

    • Identifying critical binding residues (hotspots) for subsequent design

  • Affinity Maturation: Apply computational affinity maturation protocols to design improved variants with enhanced affinity and stability compared to the original antibody .

How can machine learning be integrated into SPAC23H4.05c Antibody research and development?

Machine learning approaches offer powerful tools for antibody research, as demonstrated by rapid antibody design protocols for targets like SARS-CoV-2 . For SPAC23H4.05c Antibody research, similar principles can be applied:

  • Structure Prediction: Machine learning algorithms trained on antibody structural databases can predict SPAC23H4.05c binding domain structures with high accuracy, even when limited experimental data is available .

  • Binding Optimization: Iterative machine learning approaches can propose beneficial mutations to improve binding properties:

    • Starting with baseline free energy calculations

    • Computationally suggesting mutations to enhance binding affinity

    • Predicting interaction energy improvements (e.g., from -48.1 kcal/mol baseline to -82.0 kcal/mol after optimization, as seen in similar approaches)

  • High-Throughput Virtual Screening: Machine learning models can evaluate thousands of potential structural variants in silico, significantly accelerating the optimization process compared to traditional wet-lab methods .

  • Feedback Loop Integration: Incorporating experimental validation data back into the machine learning pipeline creates a continuous improvement cycle, enhancing model accuracy and predictive power with each iteration .

What strategies can be employed to increase SPAC23H4.05c Antibody specificity for challenging targets?

When working with SPAC23H4.05c Antibody in complex experimental systems, researchers can implement several advanced strategies to enhance specificity:

  • Computational Epitope Mapping:

    • Identify potential cross-reactivity through in silico analysis of structural homology between target and off-target proteins

    • Use alanine scanning to identify residues critical for specific binding

    • Design modified antibodies with enhanced discrimination between closely related epitopes

  • Affinity Maturation:

    • Apply computational affinity maturation protocols to alter the SPAC23H4.05c sequence systematically

    • Generate variants with optimized binding energy profiles

    • Screen resulting candidates for improved specificity-to-background ratios

  • CDR Optimization:

    • Focus modifications on the complementarity-determining regions (CDRs) that directly interact with antigens

    • Introduce targeted mutations to enhance binding site complementarity

    • Maintain framework stability while modifying binding pocket architecture

How can researchers apply cross-species conservation analysis to predict SPAC23H4.05c Antibody cross-reactivity?

Understanding potential cross-reactivity of SPAC23H4.05c Antibody across species requires systematic analysis:

  • Sequence Homology Assessment:

    • Align target epitope sequences across different species

    • Quantify conservation at key binding interface residues

    • Predict cross-reactivity based on conservation of critical contact points

  • Structural Homology Modeling:

    • Generate homology models of target proteins from different species

    • Perform computational docking with SPAC23H4.05c Antibody

    • Compare binding energies to estimate relative affinities

  • Evolutionary Conservation Analysis:

    • Examine phylogenetic relationships between target proteins

    • Identify evolutionary pressure on epitope regions

    • Correlate conservation patterns with experimentally determined cross-reactivity

What are common challenges in SPAC23H4.05c Antibody binding studies and how can they be addressed?

Researchers frequently encounter several challenges when working with antibodies like SPAC23H4.05c:

  • Inconsistent Binding Results:

    • Challenge: Variable affinity across experimental replicates

    • Solution: Standardize protein preparation protocols, implement stringent quality control for recombinant proteins, and normalize binding data to internal standards

  • Non-specific Binding:

    • Challenge: High background signal reducing signal-to-noise ratio

    • Solution: Optimize blocking conditions, increase washing stringency, and implement computational docking simulations to identify potential off-target binding sites

  • Epitope Masking:

    • Challenge: Target epitope inaccessibility in native protein conformation

    • Solution: Employ epitope mapping to confirm accessibility, use alternative sample preparation methods, or consider developing detection antibodies targeting different epitopes

  • Binding Affinity Quantification:

    • Challenge: Accurate determination of binding kinetics

    • Solution: Implement multiple orthogonal methods (SPR, BLI, ITC) and compare with computational predictions from IsAb-like protocols

How can computational approaches help interpret contradictory experimental results with SPAC23H4.05c Antibody?

When facing contradictory experimental data:

  • Structural Analysis:

    • Generate multiple potential binding conformations using RosettaAntibody

    • Evaluate energetically favorable binding poses through two-step docking

    • Identify alternative binding modes that might explain divergent results

  • Epitope Heterogeneity Assessment:

    • Use computational alanine scanning to identify potential binding hotspots

    • Evaluate target protein conformational diversity through molecular dynamics

    • Determine if contradictory results stem from epitope conformational changes

  • Binding Energy Calculations:

    • Compare experimental affinity measurements with theoretical binding energies

    • Identify conditions where theoretical and experimental values diverge

    • Use discrepancies to guide further experimental design and hypothesis generation

How might SPAC23H4.05c Antibody be engineered for novel research applications using current computational tools?

The evolving landscape of antibody engineering offers several promising directions for SPAC23H4.05c modification:

  • Therapeutic Development Pathways:

    • Apply protocols similar to those used for cemiplimab (PD-1 inhibitor) antibody to modify SPAC23H4.05c for potential therapeutic applications

    • Implement step-by-step computational design processes including structure prediction, energy minimization, and affinity maturation

  • Multi-specific Antibody Engineering:

    • Adapt SPAC23H4.05c binding domains to recognize multiple targets simultaneously

    • Employ computational design tools to optimize dual-specificity binding sites

    • Model structural constraints to maintain binding to both primary and secondary targets

  • Enhanced Functionality Engineering:

    • Modify Fc regions to alter effector functions while maintaining target specificity

    • Apply machine learning approaches to predict optimal mutations for desired functional changes

    • Implement high-throughput computational screening of variant libraries before experimental validation

What role could rapid in silico design play in adapting SPAC23H4.05c Antibody for emerging research applications?

In silico design approaches similar to those used for SARS-CoV-2 antibody development could significantly accelerate SPAC23H4.05c Antibody adaptation:

  • Rapid Response Applications:

    • Design SPAC23H4.05c variants for newly identified targets in as little as 22 days using computational pipelines

    • Generate multiple candidate sequences (e.g., 20 initial antibody sequences) predicted to bind novel targets

    • Iteratively improve binding properties through computational mutation analysis

  • Machine Learning Integration:

    • Combine bioinformatics, machine learning, and supercomputing to predict optimal SPAC23H4.05c modifications

    • Calculate baseline free energy values and systematically improve binding through predicted mutations

    • Create feedback loops that incorporate experimental validation into model refinement

  • Cross-platform Validation:

    • Compare predictions from multiple computational approaches (RosettaAntibody, machine learning models)

    • Identify consensus modifications with highest probability of success

    • Prioritize experimental validation based on computational confidence scores

By leveraging these advanced computational approaches, researchers can dramatically accelerate the adaptation of SPAC23H4.05c Antibody for novel research applications while minimizing resource-intensive experimental iterations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.